| Product Code: ETC6077994 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Andorra Neuropathic Pain Market Overview |
3.1 Andorra Country Macro Economic Indicators |
3.2 Andorra Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 Andorra Neuropathic Pain Market - Industry Life Cycle |
3.4 Andorra Neuropathic Pain Market - Porter's Five Forces |
3.5 Andorra Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Andorra Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Andorra Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Andorra Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Andorra Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 Andorra Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 Andorra Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 Andorra Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about neuropathic pain and available treatment options |
4.2.2 Growing prevalence of chronic diseases leading to neuropathic pain |
4.2.3 Advancements in medical technology and research for better pain management |
4.3 Market Restraints |
4.3.1 High cost associated with neuropathic pain treatment |
4.3.2 Limited access to specialized healthcare services in Andorra |
5 Andorra Neuropathic Pain Market Trends |
6 Andorra Neuropathic Pain Market, By Types |
6.1 Andorra Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Andorra Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Andorra Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 Andorra Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 Andorra Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 Andorra Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Andorra Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 Andorra Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Andorra Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 Andorra Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Andorra Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 Andorra Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 Andorra Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 Andorra Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 Andorra Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 Andorra Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 Andorra Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 Andorra Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 Andorra Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 Andorra Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 Andorra Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 Andorra Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 Andorra Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 Andorra Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 Andorra Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 Andorra Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 Andorra Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 Andorra Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 Andorra Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 Andorra Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 Andorra Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 Andorra Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 Andorra Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 Andorra Neuropathic Pain Market Import-Export Trade Statistics |
7.1 Andorra Neuropathic Pain Market Export to Major Countries |
7.2 Andorra Neuropathic Pain Market Imports from Major Countries |
8 Andorra Neuropathic Pain Market Key Performance Indicators |
8.1 Average wait time for neuropathic pain treatment in Andorra |
8.2 Number of healthcare providers offering specialized services for neuropathic pain |
8.3 Patient satisfaction rate with neuropathic pain treatment services |
9 Andorra Neuropathic Pain Market - Opportunity Assessment |
9.1 Andorra Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Andorra Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Andorra Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Andorra Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Andorra Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 Andorra Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 Andorra Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 Andorra Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Andorra Neuropathic Pain Market - Competitive Landscape |
10.1 Andorra Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 Andorra Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here